The initiative, dubbed ‘Chronos PD’, could accelerate the discovery of new diagnostic tools, as well as the identification ... a Dutch company through which the Grifols family controls part of its ...

The actor’s charitable foundation has just unlocked the key to flagging Parkinson’s disease early, putting us one step closer ...

The global hepatitis diagnostic test market is poised for significant growth, with market value projected to increase from USD 3621.5 million in 2024 to USD 6118.4 million by 2033, reflecting a steady ...

Grifols has received a $21 million grant from The Michael J. Fox Foundation to fund a pioneering study aimed at identifying ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

As a recognized leader in transfusion medicine, Grifols offers a comprehensive portfolio of solutions designed to enhance safety from donation to transfusion, in addition to clinical diagnostic ...

‘Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms appear, leading to new diagnostic tools and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Advancements in diagnostic methodologies have enabled us to detect the IAV at early stages by overcoming the limitations of previously used diagnostic tests, further preparing us to combat future ...